Elevai Labs Q2 EPS $(0.08) Up From $(0.128) YoY, Sales $605.53K Up From $316.53K YoY
Portfolio Pulse from Benzinga Newsdesk
Elevai Labs (NASDAQ:ELAB) reported a Q2 EPS of $(0.08), an improvement from $(0.13) YoY, and sales of $605.53K, up 91.30% YoY.
August 14, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevai Labs reported a Q2 EPS of $(0.08), an improvement from $(0.13) YoY, and sales of $605.53K, up 91.30% YoY.
The improvement in EPS and significant increase in sales are positive indicators for Elevai Labs, suggesting better financial health and growth potential. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100